CClinicalTrials.gg
Not yet recruitingNCT07542093Updated Apr 21, 2026

Bedside Lung Ultrasound to Monitor Lung Recruitment in Obese Patients

An observational study in Morbid Obesity, Obesity and Respiratory Failure, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
45
Ages
18 Years and older
Sex
All
01

Study summary

Patients with morbid obesity who require a breathing machine (mechanical ventilator) in the Intensive Care Unit (ICU) frequently experience partial lung collapse. This happens because the extra weight of the chest and abdomen presses on the lungs, reducing their capacity and making it difficult to maintain adequate oxygen levels. To address this, doctors often perform a standard lung recruitment maneuver, which involves temporarily increasing the air pressure from the ventilator to gently pop open the collapsed lung areas. However, standard bedside monitoring tools make it difficult to see exactly how well the different regions of the lungs are reopening.

This prospective observational study aims to evaluate the use of Bedside Lung Ultrasound (LUS), which is a safe, radiation-free imaging tool, to monitor how well the lungs respond to these maneuvers in real-time.

During the study, researchers will use a standardized 12-zone ultrasound scan to examine the lungs of mechanically ventilated adult patients (BMI ≥ 33 kg/m²) before, during, and after a step-by-step lung recruitment maneuver. By calculating a "Total Lung Ultrasound Score," the medical team can directly visualize and measure the transition from collapsed tissue to normal, aerated lung tissue. Furthermore, the ultrasound will be used during a step-down pressure phase to help identify the patient's "optimal PEEP" (Positive End-Expiratory Pressure), which is the exact customized pressure needed to keep the lungs open after the maneuver is complete, thereby improving oxygenation and minimizing the risk of lung injury.

Read the detailed description

The global escalation of obesity creates distinct challenges for respiratory management in the ICU. In the morbidly obese population, increased chest wall mass and cranial displacement of the diaphragm significantly elevate pleural pressure. This physiological burden leads to widespread atelectasis in dependent lung zones and a marked reduction in functional residual capacity, resulting in a cycle of atelectrauma and severe ventilation-perfusion mismatch. Traditional monitoring tools are inadequate for managing these patients: chest X-rays lack sensitivity for detecting posterior, dependent-zone collapse, Computed Tomography (CT) carries prohibitive transport risks and radiation exposure, and conventional compliance curves provide only global information that obscures regional heterogeneity. Bedside Lung Ultrasound (LUS) offers a paradigm shift by enabling real-time regional visualization of sub-pleural pathology, allowing clinicians to identify the transition from tissue-like consolidation to normal aeration at the bedside.

This study aims to evaluate the clinical utility of bedside LUS as a real-time, radiation-free monitoring tool for assessing the effectiveness of Lung Recruitment Maneuvers (LRMs) and guiding optimal Positive End-Expiratory Pressure (PEEP) titration in mechanically ventilated obese adults.

Study Procedures:

  • Baseline Assessment: Following enrollment, baseline ventilator parameters, hemodynamics, Arterial Blood Gas (ABG), static lung compliance, and driving pressure are recorded. A standardized 12-zone LUS scan is performed. Each zone is scored from 0 (A-lines predominant/normal aeration) to 3 (tissue-like consolidation/complete collapse) to calculate a total baseline LUS score.
  • Pre-Maneuver Checkpoint: Prior to initiating the maneuver, strict hemodynamic safety criteria must be confirmed, including a Mean Arterial Pressure (MAP) ≥ 65 mmHg, Heart Rate between 60-120 bpm, and SpO₂ ≥ 85%.
  • Stepwise Recruitment Maneuver: Ventilation is switched to Pressure Control (PCV) with a constant driving pressure of 15 cmH₂O. PEEP is systematically increased in 2 cmH₂O increments from 10 to a peak of 20 cmH₂O, holding each step for 5 minutes. During each step, a focused 2-zone posterior-basal LUS scan is performed bilaterally.
  • Decremental PEEP Titration: Following peak recruitment, PEEP is reduced by 2 cmH₂O every 5 minutes. A focused 4-zone posterior LUS scan is performed at each step to identify the "Closing Pressure," which is the exact PEEP level where B-lines or consolidation reappear in previously aerated zones. Optimal PEEP is calculated as the Closing Pressure plus 2 cmH₂O. A brief re-recruitment is performed before setting this final optimal PEEP.
  • Post-Maneuver Assessment: At 15-20 minutes after establishing the optimal PEEP, a full 12-zone LUS scan is repeated to calculate the post-maneuver score. Follow-up ABG, static compliance, driving pressure, and hemodynamic measurements are also recorded.

Scanning is performed by the same trained investigator throughout the study to reduce inter-observer variability, and safety stop criteria are in place to abort the maneuver if patients exhibit severe desaturation, hemodynamic instability, or signs of pneumothorax.

02

Conditions studied

  • Morbid Obesity
  • Obesity
  • Respiratory Failure
  • Atelectasis
  • Ventilator-Induced Lung Injury (VILI)

Keywords

  • Lung Ultrasound (LUS)
  • Lung Ultrasound Score
  • Lung Recruitment Maneuvers (LRM)
  • Mechanical Ventilation
  • Positive End-Expiratory Pressure (PEEP)
  • Optimal PEEP
  • Decremental PEEP Titration
03

In context

Obesity, Morbid

922 studies on the registry are indexed under Obesity, Morbid; 172 are open to participants now.

This study's planned enrollment of 45 is below the median of 78 across 306 observational studies indexed under Obesity, Morbid.

Browse Obesity, Morbid studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population consists of adult patients (aged >18 years) with morbid obesity (BMI ≥ 33 kg/m²) who are admitted to the respiratory Intensive Care Unit (ICU) at Assiut University Hospital. Patients must be intubated and receiving invasive mechanical ventilation for an expected duration of at least 6 hours, while maintaining hemodynamic stability at enrollment.

Inclusion criteria

  • Adult patients aged >18 years
  • BMI ≥ 33 kg/m² (morbid obesity)
  • Intubated and receiving invasive mechanical ventilation for any indication (elective surgery, respiratory failure, post-operative ICU admission)
  • Expected duration of mechanical ventilation ≥ 6 hours
  • Hemodynamically stable at enrollment: Mean Arterial Pressure (MAP) ≥ 65 mmHg without escalating vasopressor support
  • SpO₂ ≥ 85% on current ventilator settings
  • Written informed consent obtained from patient or legal guardian

Exclusion criteria

Exclusion Criteria:

  • Known or suspected pneumothorax or bullous emphysema (contraindication to recruitment maneuvers)
  • Severe hemodynamic instability: MAP \< 60 mmHg or requiring high-dose vasopressors (norepinephrine > 0.3 mcg/kg/min)
  • Active bronchopleural fistula
  • Recent thoracic or cardiac surgery (within 48 hours) where high airway pressures are contraindicated
  • Raised intracranial pressure (ICP) or known severe traumatic brain injury
  • Confirmed ARDS with PaO₂/FiO₂ ratio \< 100 mmHg (severe ARDS, where recruitment strategy differs significantly)
  • Chest wall deformity or subcutaneous emphysema that precludes reliable lung ultrasound assessment
  • Refusal of consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
45 participants (estimated)
Patient registry
No

Groups and cohorts

  • Mechanically Ventilated Obese Patients

    Adult patients with a BMI ≥ 33 kg/m² requiring invasive mechanical ventilation in the respiratory ICU. All participants in this single-cohort study will undergo a standardized, stepwise pressure-controlled lung recruitment maneuver reaching a peak inspiratory pressure of 35 cmH₂O and a PEEP of 20 cmH₂O. This is immediately followed by a decremental PEEP titration. The primary observational focus is the use of a bedside 12-zone Lung Ultrasound (LUS) scan to monitor real-time regional lung re-aeration, calculate total LUS scores before and after the maneuver, and identify the optimal PEEP based on lung closing pressures.

06

What researchers measure

Primary outcomes

  1. Change in Total Lung Ultrasound Score (LUS)

    The Total Lung Ultrasound Score (LUS) assesses regional lung aeration using a 12-zone scanning protocol. Each of the 12 zones is scored from 0 (normal aeration) to 3 (complete collapse/tissue-like consolidation). The total score is the sum of all 12 zones, ranging from 0 to 36, where a higher score indicates worse lung aeration. This measure evaluates the quantitative change in real-time regional re-aeration resulting from the lung recruitment maneuver.

    Time frame: Baseline (immediately before the recruitment maneuver) to 15-20 minutes after establishing optimal PEEP

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07542093
Lead sponsor
Assiut University
Responsible party
Asmaa Mostafa Hammam (Resident at Chest Diseases Department, Assiut University, Assiut University) — Principal investigator
First posted
Apr 21, 2026
Start date
May 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Apr 21, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion